Learn more about whether Immunocore Holdings plc or Recursion Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several notable portfolio adjustments on Thursday, November 20, as ...
The world is undergoing three massive platform shifts at once, the CEO said, as the stock soared more than 6% in after-hours ...
Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several notable portfolio adjustments on Tuesday, November 18, ...
Cathie Wood’s ARK ETF published their daily trades for Tuesday, November 18, 2025, showcasing significant activity in several notable stocks. The largest transaction of the day was the purchase of ...
Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...
Today’s Forbes Daily highlights Jeff Bezos’ new AI startup, Recursion fighting tough odds on drug R&D, a reality check on ...
As biotech firms worldwide grapple with crippling GPU shortages that threaten to derail AI-powered drug discovery--from protein folding simulations to genomic modeling--GNUS.ai today unveils its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback